Rimacalib has been used in trials studying the treatment of Rheumatoid Arthritis (RA). The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include N’-[3-[(1S)-1-(3-fluoro-4-phenylphenyl)ethyl]-1, 2-oxazol-5-yl]morpholine-4-carboximidamide and SMP 114. Its PubChem CID is 9800765.
Rimacalib
| CAS No | 215174-50-8 |
|---|---|
| Molecular Formula | C22H23FN4O2 |
| Molecular Weight | 394.4 g/mol |
| Synonyms | N'-[3-[(1S)-1-(3-fluoro-4-phenylphenyl)ethyl]-1,2-oxazol-5-yl]morpholine-4-carboximidamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Rimacalib has been used in trials studying the treatment of Rheumatoid Arthritis (RA). The directory classifies it as a discontinued API with a synthetic source/manufacturing origin.
The listed CAS number is 215174-50-8.
The listed molecular formula is C22H23FN4O2.
The listed molecular weight is 394.4 g/mol.
N'-[3-[(1S)-1-(3-fluoro-4-phenylphenyl)ethyl]-1,2-oxazol-5-yl]morpholine-4-carboximidamide.
The source lists N'-[3-[(1S)-1-(3-fluoro-4-phenylphenyl)ethyl]-1, 2-oxazol-5-yl]morpholine-4-carboximidamide and SMP 114.